These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 8852495)
21. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy. Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375 [TBL] [Abstract][Full Text] [Related]
22. Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience. Parving HH; Rossing P; Hommel E; Smidt UM Am J Kidney Dis; 1995 Jul; 26(1):99-107. PubMed ID: 7611276 [TBL] [Abstract][Full Text] [Related]
23. Effect of long-term therapy with captopril on proteinuria and renal function in patients with non-insulin-dependent diabetes and with non-diabetic renal diseases. Liou HH; Huang TP; Campese VM Nephron; 1995; 69(1):41-8. PubMed ID: 7891796 [TBL] [Abstract][Full Text] [Related]
25. Comparative effects of captopril versus nifedipine on proteinuria and renal function of type 2 diabetic patients. Romero R; Salinas I; Lucas A; Teixidó J; Audi L; Sanmarti A Diabetes Res Clin Pract; 1992 Sep; 17(3):191-8. PubMed ID: 1425158 [TBL] [Abstract][Full Text] [Related]
26. Effect of nifedipine and captopril on glomerular hyperfiltration in normotensive man. Böhler J; Woitas R; Keller E; Reetze-Bonorden P; Schollmeyer PJ Am J Kidney Dis; 1992 Aug; 20(2):132-9. PubMed ID: 1496965 [TBL] [Abstract][Full Text] [Related]
27. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study. Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z; Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787 [TBL] [Abstract][Full Text] [Related]
28. Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM. Chan JC; Nicholls MG; Cheung CK; Law LK; Swaminathan R; Cockram CS Diabetes Care; 1995 Jul; 18(7):1001-6. PubMed ID: 7555530 [TBL] [Abstract][Full Text] [Related]
29. Angiotensin converting enzyme inhibitors versus calcium antagonists in the treatment of diabetic hypertensive patients. Ferder L; Daccordi H; Martello M; Panzalis M; Inserra F Hypertension; 1992 Feb; 19(2 Suppl):II237-42. PubMed ID: 1735586 [TBL] [Abstract][Full Text] [Related]
30. Antihypertensive and metabolic effects of doxazosin in hypertensive patients with concomitant non-insulin-dependent diabetes mellitus. Inoue Y; Kaku K; Kaneko T; Matsumura S; Nakayama H; Yoshizaki Y; Ando S; Inoue M; Hatao M J Int Med Res; 1996; 24(1):138-46. PubMed ID: 8674792 [TBL] [Abstract][Full Text] [Related]
31. Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels. Komine N; Khang S; Wead LM; Blantz RC; Gabbai FB Am J Kidney Dis; 2002 Jan; 39(1):159-64. PubMed ID: 11774115 [TBL] [Abstract][Full Text] [Related]
32. Comparison of converting enzyme inhibitor and calcium channel blocker in hypertensive glomerular injury. Tolins JP; Raij L Hypertension; 1990 Oct; 16(4):452-61. PubMed ID: 2210813 [TBL] [Abstract][Full Text] [Related]
33. Effects of antihypertensive drugs on renal function and atrial natriuretic polypeptide in spontaneously hypertensive rats with renal ablation. Yasujima M; Abe K; Kanazawa M; Yoshida K; Kohzuki M; Sato M; Takeuchi K; Omata K; Tsunoda K; Kudo K Tohoku J Exp Med; 1989 May; 158(1):85-94. PubMed ID: 2528846 [TBL] [Abstract][Full Text] [Related]
35. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. Wright JT; Bakris G; Greene T; Agodoa LY; Appel LJ; Charleston J; Cheek D; Douglas-Baltimore JG; Gassman J; Glassock R; Hebert L; Jamerson K; Lewis J; Phillips RA; Toto RD; Middleton JP; Rostand SG; JAMA; 2002 Nov; 288(19):2421-31. PubMed ID: 12435255 [TBL] [Abstract][Full Text] [Related]
36. Effect of antihypertensive drugs on glomerular hyperfiltration and renal haemodynamics. Comparison of captopril with nifedipine, metoprolol and celiprolol. Böhler J; Becker A; Reetze-Bonorden P; Woitas R; Keller E; Schollmeyer P Eur J Clin Pharmacol; 1993; 44 Suppl 1():S57-61. PubMed ID: 8486148 [TBL] [Abstract][Full Text] [Related]
37. Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients. Yokoyama H; Tomonaga O; Hirayama M; Ishii A; Takeda M; Babazono T; Ujihara U; Takahashi C; Omori Y Diabetologia; 1997 Apr; 40(4):405-11. PubMed ID: 9112017 [TBL] [Abstract][Full Text] [Related]
38. Comparative effects of captopril and nifedipine on split renal function in renovascular hypertension. Miyamori I; Yasuhara S; Matsubara T; Takasaki H; Takeda R Am J Hypertens; 1988 Oct; 1(4 Pt 1):359-63. PubMed ID: 3063285 [TBL] [Abstract][Full Text] [Related]
39. Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients. Velussi M; Brocco E; Frigato F; Zolli M; Muollo B; Maioli M; Carraro A; Tonolo G; Fresu P; Cernigoi AM; Fioretto P; Nosadini R Diabetes; 1996 Feb; 45(2):216-22. PubMed ID: 8549868 [TBL] [Abstract][Full Text] [Related]
40. Alpha-adrenoceptor blockade in patients with mild to moderate hypertension: long-term renal effects of doxazosin. Krusell LR; Christensen CK; Pedersen OL J Cardiovasc Pharmacol; 1992 Sep; 20(3):440-4. PubMed ID: 1279290 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]